UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in SANA — Sana Biotechnology, Inc.
CIK 861177
NEW YORK, NY
Position in SANA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$992,804
+$325,492 QoQ
Shares Held
284,472
+22.8% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 211 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 25%
Shared 0%
None 75%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. SANA ranks #118 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in SANA
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $992,804 | 284,472 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $667,312 | 231,706 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $978,482 | 240,414 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $499,295 | 140,647 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $478,669 | 284,924 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $455,225 | 279,282 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,056,217 | 253,899 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,349,032 | 247,076 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $833,470 | 83,347 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $266,353 | 65,283 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $222,891 | 57,595 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $225,394 | 37,818 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $123,664 | 37,818 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $207,840 | 52,618 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $315,708 | 52,618 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $466,818 | 72,600 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $203,196 | 24,600 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $380,808 | 24,600 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||